Linagliptin + Metformin Hydrochloride
Indications
Linagliptin + Metformin Hydrochloride is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It suits people for whom treatment with both Linagliptin and Metformin Hydrochloride is appropriate.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Linagliptin is used to improve blood sugar control in people with type 2 diabetes mellitus. It blocks DPP-4 (dipeptidyl peptidase-4), an enzyme that breaks down the incretin hormones GLP-1 (glucagon like peptide-1) and GIP (glucose dependent insulinotropic polypeptide). With the enzyme blocked, linagliptin raises the level of active incretin hormones. These hormones stimulate the pancreatic beta (β) cells to release insulin, and they do so in a glucose-dependent manner. They also reduce the amount of glucagon that the pancreatic alpha (α) cells release into the circulation.
Metformin Hydrochloride is a biguanide type of oral antihyperglycemic medicine, used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from that of the sulfonylureas, and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production and decreases intestinal absorption of glucose. It also improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Pregnancy & Breastfeeding
No adequate and well-controlled studies have been done in pregnant women with linagliptin and metformin hydrochloride together, or with either medicine on its own. So the combination should be used during pregnancy only if it is clearly needed. Take care too when giving it to a breastfeeding mother.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.